vs
Side-by-side financial comparison of Eastman Chemical Company (EMN) and Globe Life (GL). Click either name above to swap in a different company.
Eastman Chemical Company is the larger business by last-quarter revenue ($2.0B vs $1.6B, roughly 1.3× Globe Life). Globe Life runs the higher net margin — 17.3% vs 5.3%, a 12.0% gap on every dollar of revenue. On growth, Globe Life posted the faster year-over-year revenue change (5.3% vs -13.8%). Over the past eight quarters, Globe Life's revenue compounded faster (4.1% CAGR vs -8.6%).
Eastman Chemical Company is an American chemical products manufacturer based in Kingsport, Tennessee. Founded in 1920, it was formerly a subsidiary of Kodak until 1994. The company is an independent global specialty materials company that produces a broad range of advanced materials, chemicals and fibers for everyday purposes. It operates 36 manufacturing sites worldwide and employs approximately 14,000 people. In 2023, Eastman had sales revenue of approximately $9.21 billion.
Globe Life Inc. (GL) is an American financial services holding company listed on the New York Stock Exchange which operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.
EMN vs GL — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.6B |
| Net Profit | $105.0M | $270.5M |
| Gross Margin | 17.1% | — |
| Operating Margin | — | — |
| Net Margin | 5.3% | 17.3% |
| Revenue YoY | -13.8% | 5.3% |
| Net Profit YoY | -42.3% | 6.3% |
| EPS (diluted) | $0.93 | $3.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.0B | $1.6B | ||
| Q4 25 | $2.0B | $1.5B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.3B | $1.5B | ||
| Q4 24 | $2.2B | $1.5B | ||
| Q3 24 | $2.5B | $1.5B | ||
| Q2 24 | $2.4B | $1.4B |
| Q1 26 | $105.0M | $270.5M | ||
| Q4 25 | $105.0M | $266.1M | ||
| Q3 25 | $47.0M | $387.8M | ||
| Q2 25 | $140.0M | $252.7M | ||
| Q1 25 | $182.0M | $254.6M | ||
| Q4 24 | $330.0M | $255.2M | ||
| Q3 24 | $180.0M | $303.0M | ||
| Q2 24 | $230.0M | $258.4M |
| Q1 26 | 17.1% | — | ||
| Q4 25 | 17.1% | — | ||
| Q3 25 | 19.7% | — | ||
| Q2 25 | 22.1% | — | ||
| Q1 25 | 24.8% | — | ||
| Q4 24 | 24.7% | — | ||
| Q3 24 | 24.6% | 26.1% | ||
| Q2 24 | 25.3% | 23.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | 21.7% | ||
| Q3 25 | 6.1% | 31.5% | ||
| Q2 25 | 7.4% | 21.2% | ||
| Q1 25 | 11.0% | 21.4% | ||
| Q4 24 | 13.2% | 21.3% | ||
| Q3 24 | 11.4% | 26.3% | ||
| Q2 24 | 12.1% | 23.5% |
| Q1 26 | 5.3% | 17.3% | ||
| Q4 25 | 5.3% | 17.5% | ||
| Q3 25 | 2.1% | 25.6% | ||
| Q2 25 | 6.1% | 17.1% | ||
| Q1 25 | 7.9% | 17.2% | ||
| Q4 24 | 14.7% | 17.4% | ||
| Q3 24 | 7.3% | 20.8% | ||
| Q2 24 | 9.7% | 17.9% |
| Q1 26 | $0.93 | $3.39 | ||
| Q4 25 | $0.93 | $3.28 | ||
| Q3 25 | $0.40 | $4.73 | ||
| Q2 25 | $1.20 | $3.05 | ||
| Q1 25 | $1.57 | $3.01 | ||
| Q4 24 | $2.81 | $3.00 | ||
| Q3 24 | $1.53 | $3.44 | ||
| Q2 24 | $1.94 | $2.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $566.0M | $183.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $6.0B | $6.1B |
| Total Assets | $14.9B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $566.0M | $183.8M | ||
| Q4 25 | $566.0M | $314.7M | ||
| Q3 25 | — | $62.8M | ||
| Q2 25 | — | $116.7M | ||
| Q1 25 | — | $134.1M | ||
| Q4 24 | $837.0M | $85.0M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $100.6M |
| Q1 26 | $6.0B | $6.1B | ||
| Q4 25 | $6.0B | $6.0B | ||
| Q3 25 | $5.8B | $5.7B | ||
| Q2 25 | $5.8B | $5.4B | ||
| Q1 25 | $5.9B | $5.4B | ||
| Q4 24 | $5.8B | $5.3B | ||
| Q3 24 | $5.7B | $4.6B | ||
| Q2 24 | $5.6B | $5.2B |
| Q1 26 | $14.9B | — | ||
| Q4 25 | $14.9B | $30.8B | ||
| Q3 25 | $15.0B | $30.5B | ||
| Q2 25 | $15.2B | $29.8B | ||
| Q1 25 | $15.0B | $29.7B | ||
| Q4 24 | $15.2B | $29.1B | ||
| Q3 24 | $15.1B | $29.6B | ||
| Q2 24 | $14.9B | $28.3B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EMN
Segment breakdown not available.
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
